abstract |
The present invention relates to the following general formula: wherein R1 and R5 are independently hydrogen, halogen, optionally halogenated methyl or methoxy; R2, R4 are independently hydrogen, branched alkyl, halogen, optionally halogenated methyl, wherein at least one of the groups R2 and R4 is branched alkyl, and R3 is hydrogen, halogen or optionally halogenated methyl - having a methyl substituent on the phenyl ring. -phenyl) -imino] -imidazolidine derivatives and / or their pharmacologically acceptable salts and / or tautomeric forms and medicaments, in particular for use in the treatment of urinary incontinence. HE |